Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer

Clinical trial NCT03044587 · COMPLETED

Trial details

NCT number: NCT03044587
Sponsor: AIO-Studien-gGmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma Metastatic Biliary Tract Cancer Adenocarcinoma of the Biliary Tract Adenocarinoma Locally Advanced Non-Resectable Hepatocellular Carcinoma Intrahepatic Bile Duct Carcinoma Extrahepatic Bile Duct Carcinoma

Start date: 2018-01-24
Primary completion: 2022-01-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.